Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib.

ABSTRACT:

SUBMITTER: Alharbi M 

PROVIDER: S-EPMC7446437 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature